Similar articles for PMID: 34244223

Year	Number of Results
2012	1
2013	2
2014	1
2015	6
2016	10
2017	19
2018	27
2019	32
2020	38
2021	90
2022	127
2023	36
2024	1

1

Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with ⁶⁸Ga-PSMA-11 PET/CT.

Kalshetty A, Menon B, Rakshit S, Bhattacharjee A, Basu S. Kalshetty A, et al. J Nucl Med Technol. 2021 Sep;49(3):235-240. doi: 10.2967/jnmt.120.261289. Epub 2021 Jul 9. J Nucl Med Technol. 2021. PMID: 34244223 Free article.

2

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

3

Eligibility for ¹⁷⁷Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of ⁶⁸Ga-PSMA-11 and ^99mTc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer.

Cook GJR, Wong WL, Sanghera B, Mangar S, Challapalli A, Bahl A, Bassett P, Leaning D, Schmidkonz C. Cook GJR, et al. J Nucl Med. 2023 Feb;64(2):227-231. doi: 10.2967/jnumed.122.264296. Epub 2022 Oct 27. J Nucl Med. 2023. PMID: 36302657 Free PMC article.

4

Examining Absorbed Doses of Indigenously Developed ¹⁷⁷Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Patients at Baseline and During Course of Peptide Receptor Radioligand Therapy.

Kamaldeep, Wanage G, Sahu SK, Maletha P, Adnan A, Suman S, Basu S, Das T, Banerjee S. Kamaldeep, et al. Cancer Biother Radiopharm. 2021 Apr;36(3):292-304. doi: 10.1089/cbr.2020.3640. Epub 2020 May 5. Cancer Biother Radiopharm. 2021. PMID: 32379495

5

Evaluation of Practical Interpretation Hurdles in 68Ga-PSMA PET/CT in 55 Patients: Physiological Tracer Distribution and Incidental Tracer Uptake.

Kirchner J, Schaarschmidt BM, Sawicki LM, Heusch P, Hautzel H, Ermert J, Rabenalt R, Antoch G, Buchbender C. Kirchner J, et al. Clin Nucl Med. 2017 Jul;42(7):e322-e327. doi: 10.1097/RLU.0000000000001672. Clin Nucl Med. 2017. PMID: 28481787

6

Prostate-Specific Membrane Antigen Radioligand Therapy Using ¹⁷⁷Lu-PSMA I&T and ¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry.

Schuchardt C, Zhang J, Kulkarni HR, Chen X, Müller D, Baum RP. Schuchardt C, et al. J Nucl Med. 2022 Aug;63(8):1199-1207. doi: 10.2967/jnumed.121.262713. Epub 2021 Dec 9. J Nucl Med. 2022. PMID: 34887335 Free PMC article.

7

Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for ⁶⁸Ga-PSMA-11 PET/CT.

Uprimny C, Bayerschmidt S, Kroiss AS, Fritz J, Nilica B, Svirydenka H, Decristoforo C, von Guggenberg E, Horninger W, Virgolini IJ. Uprimny C, et al. J Nucl Med. 2021 Nov;62(11):1550-1557. doi: 10.2967/jnumed.120.261866. Epub 2021 Mar 12. J Nucl Med. 2021. PMID: 33712533 Free PMC article.

8

Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging.

Demirci E, Sahin OE, Ocak M, Akovali B, Nematyazar J, Kabasakal L. Demirci E, et al. Nucl Med Commun. 2016 Nov;37(11):1169-79. doi: 10.1097/MNM.0000000000000566. Nucl Med Commun. 2016. PMID: 27333090

9

Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.

Prasad V, Steffen IG, Diederichs G, Makowski MR, Wust P, Brenner W. Prasad V, et al. Mol Imaging Biol. 2016 Jun;18(3):428-36. doi: 10.1007/s11307-016-0945-x. Mol Imaging Biol. 2016. PMID: 27038316

10

Tumor Sink Effect in ⁶⁸Ga-PSMA-11 PET: Myth or Reality?

Gafita A, Wang H, Robertson A, Armstrong WR, Zaum R, Weber M, Yagubbayli F, Kratochwil C, Grogan TR, Nguyen K, Navarro F, Esfandiari R, Rauscher I, Menze B, Elashoff D, Delpassand ES, Herrmann K, Czernin J, Hofman MS, Calais J, Fendler WP, Eiber M. Gafita A, et al. J Nucl Med. 2022 Feb;63(2):226-232. doi: 10.2967/jnumed.121.261906. Epub 2021 May 28. J Nucl Med. 2022. PMID: 34049987 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

318 results

Results by year